Myrtocomuloacetalone 1 as an anti-inflammatory agent
US9701690B2 · kind B2 · utility
0Cited by
0References
2Claims
0Family size
Inventors
Key dates
| Filing date | Mar 19, 2014 |
| Grant date | Jul 11, 2017 |
| Priority date | — |
| Expiry date | Mar 19, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D493/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A novel compound Myrtocomuloacetalone 1 (MCA-1) exhibiting potent anti-inflammatory properties by inhibiting production of reactive oxygen species, including nitric oxide, superoxide, and hydrogen peroxide that effectively suppresses proliferation of T-cells and also reduces intracellular oxidative stress and inhibits NF kappa B activation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.